Lista de obras - Soila Sukupolvi-Petty - Dominio Público Uruguay

Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein

artículo científico publicado en 2006

Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins ⬇️

artículo científico publicado en 2008

Correction: In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection

Correction: Therapeutic Efficacy of Antibodies Lacking Fc. Receptor Binding against Lethal Dengue Virus Infection Is Due to Neutralizing Potency and Blocking of Enhancing Antibodies.

artículo científico publicado en 2013

Dengue virus neutralization is modulated by IgG antibody subclass and Fcγ receptor subtype

artículo científico publicado en 2009

Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection

artículo científico publicado en 2013

Genotype-specific neutralization and protection by antibodies against dengue virus type 3.

artículo científico publicado en 2010

In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection

artículo científico publicado en 2011

Mosquito Bite Delivery of Dengue Virus Enhances Immunogenicity and Pathogenesis in Humanized Mice ⬇️

artículo científico publicado el 9 de mayo de 2012

On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes

artículo científico publicado en 2009

Protection by immunoglobulin dual-affinity retargeting antibodies against dengue virus

artículo científico publicado en 2013

Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.

artículo científico publicado en 2010

The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1

artículo científico publicado en 2010

The Haemophilus influenzae Type b hcsA and hcsB gene products facilitate transport of capsular polysaccharide across the outer membrane and are essential for virulence

artículo científico publicado en 2006

The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity

artículo científico publicado en 2010

The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein

artículo científico publicado en 2013

Therapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected].

artículo científico publicado en 2013

Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes

artículo científico publicado en 2007

Lista de obras de Soila Sukupolvi-Petty

Antibody Recognition and Neutralization Determinants on Domains I and II of West Nile Virus Envelope Protein

Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins ⬇️

Correction: In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection

Correction: Therapeutic Efficacy of Antibodies Lacking Fc. Receptor Binding against Lethal Dengue Virus Infection Is Due to Neutralizing Potency and Blocking of Enhancing Antibodies.

Dengue virus neutralization is modulated by IgG antibody subclass and Fcγ receptor subtype

Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection

Genotype-specific neutralization and protection by antibodies against dengue virus type 3.

In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection

Mosquito Bite Delivery of Dengue Virus Enhances Immunogenicity and Pathogenesis in Humanized Mice ⬇️

On a mouse monoclonal antibody that neutralizes all four dengue virus serotypes

Protection by immunoglobulin dual-affinity retargeting antibodies against dengue virus

Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2.

The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1

The Haemophilus influenzae Type b hcsA and hcsB gene products facilitate transport of capsular polysaccharide across the outer membrane and are essential for virulence

The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity

The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein

Therapeutic efficacy of antibodies lacking Fcγ receptor binding against lethal dengue virus infection is due to neutralizing potency and blocking of enhancing antibodies [corrected].

Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes